Abvc Biopharma Stock Performance

ABVC Stock  USD 1.90  0.01  0.53%   
The firm shows a Beta (market volatility) of 0.63, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, ABVC Biopharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding ABVC Biopharma is expected to be smaller as well. At this point, ABVC Biopharma has a negative expected return of -0.59%. Please make sure to confirm ABVC Biopharma's accumulation distribution, and the relationship between the potential upside and day median price , to decide if ABVC Biopharma performance from the past will be repeated in the future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days ABVC Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2026. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Last Split Factor
1:10
Dividend Date
2019-05-08
Last Split Date
2023-07-25
1
Will ABVC BioPharma Inc. stock sustain high P E ratios - 2025 Price Action Summary Risk Controlled Daily Trade Plans - newser.com
11/11/2025
2
How ABVC BioPharma Inc. stock benefits from strong dollar - IPO Watch Target Return Focused Stock Picks - newser.com
11/14/2025
3
Is ABVC BioPharma Inc. stock cheap compared to fundamentals - 2025 Institutional Moves Consistent Profit Trade Alerts - newser.com
11/19/2025
4
Acquisition by Smith J.b. of 500000 shares of ABVC Biopharma at 0.9 subject to Rule 16b-3
11/20/2025
5
Disposition of tradable shares by King Chi-hsin Richard of ABVC Biopharma subject to Rule 16b-3
11/25/2025
6
Acquisition by Smith J.b. of 11500 shares of ABVC Biopharma at 0.75 subject to Rule 16b-3
12/03/2025
7
Acquisition by Ramsey Sally Judith of tradable shares of ABVC Biopharma at 80000.0 subject to Rule 16b-3
12/12/2025
8
Can ABVC BioPharma Inc. stock hit analyst price targets - July 2025 Technicals Low Risk Growth Stock Ideas -
12/19/2025
9
What momentum indicators show for ABVC BioPharma Inc. stock - 2026 world cup usa national team quarterfinals star players transition play group prediction analy...
01/06/2026
10
Aug Swings Is ABVC BioPharma Inc stock good for income investors - Weekly Market Summary Expert Approved Momentum Trade Ideas - baoquankhu1.vn
01/12/2026
11
Acquisition by Smith J.b. of tradable shares of ABVC Biopharma at 55000.0 subject to Rule 16b-3
02/02/2026

ABVC Biopharma Relative Risk vs. Return Landscape

If you would invest  284.00  in ABVC Biopharma on November 6, 2025 and sell it today you would lose (94.00) from holding ABVC Biopharma or give up 33.1% of portfolio value over 90 days. ABVC Biopharma is currently does not generate positive expected returns and assumes 3.9351% risk (volatility on return distribution) over the 90 days horizon. In different words, 35% of stocks are less volatile than ABVC, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days ABVC Biopharma is expected to under-perform the market. In addition to that, the company is 5.24 times more volatile than its market benchmark. It trades about -0.15 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.11 per unit of volatility.

ABVC Biopharma Target Price Odds to finish over Current Price

The tendency of ABVC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 1.90 90 days 1.90 
more than 93.0
Based on a normal probability distribution, the odds of ABVC Biopharma to move above the current price in 90 days from now is more than 93.0 (This ABVC Biopharma probability density function shows the probability of ABVC Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days ABVC Biopharma has a beta of 0.63. This suggests as returns on the market go up, ABVC Biopharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding ABVC Biopharma will be expected to be much smaller as well. Additionally ABVC Biopharma has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   ABVC Biopharma Price Density   
       Price  

Predictive Modules for ABVC Biopharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ABVC Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ABVC Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.101.905.80
Details
Intrinsic
Valuation
LowRealHigh
0.091.825.72
Details
Naive
Forecast
LowNextHigh
0.041.955.86
Details
1 Analysts
Consensus
LowTargetHigh
1.842.022.24
Details

ABVC Biopharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. ABVC Biopharma is not an exception. The market had few large corrections towards the ABVC Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ABVC Biopharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ABVC Biopharma within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.53
β
Beta against Dow Jones0.63
σ
Overall volatility
0.33
Ir
Information ratio -0.14

ABVC Biopharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ABVC Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ABVC Biopharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
ABVC Biopharma generated a negative expected return over the last 90 days
ABVC Biopharma may become a speculative penny stock
ABVC Biopharma has high historical volatility and very poor performance
ABVC Biopharma has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 509.59 K. Net Loss for the year was (5.26 M) with profit before overhead, payroll, taxes, and interest of 797.92 K.
ABVC Biopharma currently holds about 2.99 M in cash with (1.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09.
Latest headline from MacroaxisInsider: Acquisition by Smith J.b. of tradable shares of ABVC Biopharma at 55000.0 subject to Rule 16b-3

ABVC Biopharma Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ABVC Stock often depends not only on the future outlook of the current and potential ABVC Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ABVC Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding11.7 M
Cash And Short Term Investments928.6 K

ABVC Biopharma Fundamentals Growth

ABVC Stock prices reflect investors' perceptions of the future prospects and financial health of ABVC Biopharma, and ABVC Biopharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ABVC Stock performance.

About ABVC Biopharma Performance

By analyzing ABVC Biopharma's fundamental ratios, stakeholders can gain valuable insights into ABVC Biopharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ABVC Biopharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ABVC Biopharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand2.1 K2.3 K
Return On Tangible Assets(0.75)(0.79)
Return On Capital Employed(5.51)(5.78)
Return On Assets(0.75)(0.79)
Return On Equity(3.60)(3.42)

Things to note about ABVC Biopharma performance evaluation

Checking the ongoing alerts about ABVC Biopharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ABVC Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
ABVC Biopharma generated a negative expected return over the last 90 days
ABVC Biopharma may become a speculative penny stock
ABVC Biopharma has high historical volatility and very poor performance
ABVC Biopharma has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 509.59 K. Net Loss for the year was (5.26 M) with profit before overhead, payroll, taxes, and interest of 797.92 K.
ABVC Biopharma currently holds about 2.99 M in cash with (1.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09.
Latest headline from MacroaxisInsider: Acquisition by Smith J.b. of tradable shares of ABVC Biopharma at 55000.0 subject to Rule 16b-3
Evaluating ABVC Biopharma's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate ABVC Biopharma's stock performance include:
  • Analyzing ABVC Biopharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ABVC Biopharma's stock is overvalued or undervalued compared to its peers.
  • Examining ABVC Biopharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating ABVC Biopharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ABVC Biopharma's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of ABVC Biopharma's stock. These opinions can provide insight into ABVC Biopharma's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating ABVC Biopharma's stock performance is not an exact science, and many factors can impact ABVC Biopharma's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for ABVC Stock analysis

When running ABVC Biopharma's price analysis, check to measure ABVC Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABVC Biopharma is operating at the current time. Most of ABVC Biopharma's value examination focuses on studying past and present price action to predict the probability of ABVC Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABVC Biopharma's price. Additionally, you may evaluate how the addition of ABVC Biopharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Global Correlations
Find global opportunities by holding instruments from different markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges